Association between clinical evaluation and self perception of deglutition with motor disability scale in patients with multiple sclerosis
Associação entre avaliação clínica e autopercepção da deglutição com a escala de incapacidade motora em pacientes com esclerose múltipla
Dandara Tailuma Weiler Piloti; Vânia Carolina Devitte Ruiz; Marlise de Castro Ribeiro; Sheila Tamanini de Almeida
Abstract
Purpose: To investigate the association between the clinical evaluation and self-perception of deglutition with the motor disability scale in patients with Multiple Sclerosis. Methods: It is a cross-sectional, prospective study that was conducted with individuals with Multiple Sclerosis treated by the Neuroimmunology outpatient clinic of a hospital in southern Brazil. We reviewed the electronic medical records of patients to extract the score from the last Expanded Disability Status Scale. After the analysis of the inclusion criteria, and in clinical consultation, two protocols were applied: one of self-perception for the risk of dysphagia, through the Brazilian equivalence instrument of the Eating Assessment Tool; and the clinical evaluation of swallowing, with food, through the scale Gugging Swallowing Screen. The data were analyzed through tables, descriptive statistics and the tests: Fisher’s Exact Association Test and Chi-square Test to assess the association between the results of the applied scales. We considered a maximum significance level of 5% (p <0.05). Results: It was possible to observe that there was a significant association between the scores of the Gugging Swallowing Screen scales with the Expanded Disability Status Scale of the patients. In addition, there was also a relation between the results of both protocols with the Expanded Disability Status Scale. Conclusion: The patients with Multiple Sclerosis in this study presented oropharyngeal dysphagia, what was confirmed by the association between the clinical evaluation of swallowing and the results of the instrument of self-perception of swallowing and the motor disability scale.
Keywords
Resumo
Objetivo: Investigar a associação entre a avaliação clínica e autopercepção da deglutição com a escala de incapacidade motora em pacientes com Esclerose Múltipla. Método: Estudo transversal, prospectivo realizado com indivíduos com Esclerose Múltipla atendidos pelo ambulatório de Neuroimunologia de um hospital do sul do Brasil. Realizamos a revisão dos prontuários eletrônicos dos pacientes para extração do escore da última Expanded Disability Status Scale. Após a análise dos critérios de inclusão, e em consulta clínica, foram aplicados dois protocolos, o de autopercepção para o risco de disfagia, através do instrumento de equivalência brasileira do Eating Assessment Tool e a avaliação clínica da deglutição, com alimentos, através da escala Gugging Swallowing Screen. Os dados foram analisados através de tabelas, estatísticas descritivas e pelos testes: Teste de Associação Exato de Fisher e Teste Qui-quadrado para avaliar a associação entre os resultados das escalas aplicadas. Consideramos um nível de significância máximo de 5% (p<0,05). Resultados: Foi possível observar que houve associação significativa entre os escores das escalas Gugging Swallowing Screen com a Expanded Disability Status Scale dos pacientes. Além disso, também se observou relação entre os resultados de ambos protocolos com a Expanded Disability Status Scale. Conclusão: Os pacientes com Esclerose Múltipla deste estudo apresentaram disfagia orofaríngea. Houve associação entre os achados da avaliação clínica, do instrumento de autopercepção da deglutição e da escala de incapacidade motora em pacientes com esclerose múltipla.
Palavras-chave
Referências
1. McKay KA, Kwan V, Duggan T, Tremlett H. Risk factors associated with the onset of relapsing-remitting and primary progressive multiple sclerosis: a systematic review. BioMed Res Int. 2015;2015:817238. http://dx.doi. org/10.1155/2015/817238. PMid:25802867.
2. Batista C, Emile L, Gonçalves C, Sousa TP, Aoyama EDA. Qualidade de vida em portadores de esclerose múltipla. ReBIS. 2019;1(3):54-9.
3. Kamińska J, Koper OM, Piechal K, Kemona H. Multiple sclerosis - etiology and diagnostic potential. Postepy Hig Med Dosw. 2017;71(0):551-63. PMid:28665284.
4. Belbasis L, Bellou V, Evangelou E, Tzoulaki I. Environmental factors and risk of multiple sclerosis: findings from meta-analyses and Mendelian randomization studies. Mult Scler. 2020;26(4):397-404. http://dx.doi. org/10.1177/1352458519872664. PMid:32249718.
5. ABEM: Associação Brasileira de Esclerose Múltipla. Atlas da EM 2013: mapeamento da Esclerose Múltipla no mundo [Internet]. 2013 [citado em 2020 Set 15]. Disponível em: https://www.msif.org/wp-content/ uploads/2014/11/Atlas-of-MS-Portuguese-web2.pdf.
6. Ribeiro TAGJ, Duarte AL, Silva DJD, Borges FE, Costa VMD, PapaisAlvarenga RM, et al. Prevalence of multiple sclerosis in Goiânia, Goiás, Brazil. Arq Neuropsiquiatr. 2019;77(5):352-6. http://dx.doi.org/10.1590/0004- 282x20190032. PMid:31189000.
7. Marques VD, Passos GRD, Mendes MF, Callegaro D, Lana-Peixoto MA, Comini-Frota ER, et al. Brazilian consensus for the treatment of multiple sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple Sclerosis. Arq Neuropsiquiatr. 2018;76(8):539-54. http://dx.doi.org/10.1590/0004-282x20180078. PMid:30231128.
8. Giovannoni G. Personalized medicine in multiple sclerosis. Neurodegener Dis Manag. 2017;7(6s):13-7. http://dx.doi.org/10.2217/nmt-2017-0035. PMid:29143582.
9. Brasil. Ministério da Saúde. Portaria Conjunta nº 10, de 02 de abril de 2018. Aprova o Protocolo Clínico e Diretrizes Terapêuticas da Esclerose Múltipla. Diário Oficial União; Brasília; 02 abril 2018.
10. Luchesi KF, Campos BM, Mituuti CT. Identification of swallowing disorders: the perception of patients with neurodegenerative diseases. CoDAS. 2018;30(6):e20180027. PMid:30517269.
11. Leite AAS, Guimarães MF, Nunes JDA, Azevedo EHM. Fadiga e disfagia orofaríngea em pacientes com esclerose múltipla. Distúrb Comun. 2020;32(1):105-13. http://dx.doi.org/10.23925/2176-2724.2020v32i1p105-113.
12. Tarameshlu M, Azimi AR, Ghelichi L, Ansari NN. Prevalence and predictors of dysphagia in Iranian patients with multiple sclerosis. Med J Islam Repub Iran. 2017;31:133. http://dx.doi.org/10.14196/mjiri.31.133. PMid:29951433.
13. Warnecke T, Im S, Kaiser C, Hamacher C, Oelenberg S, Dziewas R. Aspiration and dysphagia screening in acute stroke - the Gugging Swallowing Screen revisited. Eur J Neurol. 2017;24(4):594-601. http://dx.doi.org/10.1111/ ene.13251. PMid:28322006.
14. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology. 1983;33(11):1444-52. http:// dx.doi.org/10.1212/WNL.33.11.1444. PMid:6685237.
15. Gonçalves MI, Remaili CB, Behlau M. Cross-cultural adaptation of the Brazilian version of the Eating Assessment Tool - EAT-10. CoDAS. 2013;25(6):601-4. http://dx.doi.org/10.1590/S2317-17822013.05000012. PMid:24626972.
16. Alali D, Ballard K, Vucic S, Bogaardt H. Dysphagia in multiple sclerosis: evaluation and validation of the DYMUS questionnaire. Dysphagia. 2018;33(3):273-81. http://dx.doi.org/10.1007/s00455-017-9864-5. PMid:29147920.
17. Keage M, Delatycki M, Corben L, Vogel A. A systematic review of selfreported swallowing assessments in progressive neurological disorders. Dysphagia. 2015;30(1):27-46. http://dx.doi.org/10.1007/s00455-014-9579-9. PMid:25280814.
18. Amaral IJ, Guimarães VC, Diniz DS, Carneiro MAD. Clinical swallowing evaluation in multiple sclerosis at a reference center in the center-west of Brazil. Braz J Develop. 2020;6(7):51166-78. http://dx.doi.org/10.34117/ bjdv6n7-674.
19. Errante PR, Ferraz RRN, Rodrigues FSM. Esclerose múltipla: tratamento farmacológico e revisão de literatura. UNILUS. 2016;13(30):105-17.
20. Santos VAD, Vieira ACC, Silva HJD. Electrical activity of the masseter and supra hyoid muscles during swallowing of patients with multiple sclerosis. CoDAS. 2019;31(6):e20180207. http://dx.doi.org/10.1590/2317- 1782/20192018207. PMid:31800879.
21. Ribas MLV, Ribeiro NMS. Análise da fadiga em pacientes com esclerose múltipla: um estudo preliminar. Cad Pós-Grad Distúrb Desenvolv. 2017;17(1):77-86.
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email